Velphoro

Active Ingredient(s): Sucroferric Oxyhydroxide
FDA Approved: * November 27, 2013
Pharm Company: * VIFOR FRESENIUS MEDICAL CARE RENAL PHARMA FRANCE
Category: Hyperphosphatemia

Phosphate binders are medications used to reduce the absorption of dietary phosphate; they are taken along with meals and snacks. They are frequently used in people with chronic kidney failure (CKF), who are less able to excrete phosphate, resulting in an elevated serum phosphate. Contents 1 Mechanism of action 2 Medical use 3 Adverse effects 4 Choice of agent 4.1 Types 5 References 6 External links 6.1 Common Phosphate Binders Mechanism of action These agents work by binding to ... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Velphoro PA;500
Velphoro 500 mg/1 Oral Tablet, Chewable
NDC: 49230-645
Labeler:
Fresenius Medical Care North America